Report overview
Cardiovascular surgery is the process performed to cure the heart tissue defects such as replacing the diseased heart valves if it is blocked, grafting or replacement of heart tissues in case of damage.
This report contains market size and forecasts of Cardiovascular Surgical Devices and Technologies in global, including the following market information:
Global Cardiovascular Surgical Devices and Technologies Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Cardiovascular Surgical Devices and Technologies Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Cardiovascular Surgical Devices and Technologies companies in 2021 (%)
The global Cardiovascular Surgical Devices and Technologies market was valued at 1439.9 million in 2021 and is projected to reach US$ 1842.1 million by 2028, at a CAGR of 3.6% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Beating Heart Surgery Systems Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Cardiovascular Surgical Devices and Technologies include Abbott Cardiovascular, Abiomed, Boston Scientific, C.R. Bard, Abbott, Thoratec Laboratories, Transmedics, Cook Medical and Cordis and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Cardiovascular Surgical Devices and Technologies manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cardiovascular Surgical Devices and Technologies Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Cardiovascular Surgical Devices and Technologies Market Segment Percentages, by Type, 2021 (%)
Beating Heart Surgery Systems
Perfusion Disposables
CPB Equipment
Cardiac Ablation Devices
Global Cardiovascular Surgical Devices and Technologies Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Cardiovascular Surgical Devices and Technologies Market Segment Percentages, by Application, 2021 (%)
Hospital
Academic And Medical Institutes
Others
Global Cardiovascular Surgical Devices and Technologies Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Cardiovascular Surgical Devices and Technologies Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cardiovascular Surgical Devices and Technologies revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Cardiovascular Surgical Devices and Technologies revenues share in global market, 2021 (%)
Key companies Cardiovascular Surgical Devices and Technologies sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Cardiovascular Surgical Devices and Technologies sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott Cardiovascular
Abiomed
Boston Scientific
C.R. Bard
Abbott
Thoratec Laboratories
Transmedics
Cook Medical
Cordis
Angiodynamics
